Notification

Error

Phase 3 trial - Merck

User
Posted 09 Nov 2026 at 08:27

Hi there

is anyone participating in the phase 3 trial with Merck Company taking Ifinatamab deruxtecan against normal chemo?

 

 

User
Posted 12 Nov 2026 at 10:59

Hi Smilla7,

This study is looking at the use of Ifinatamab Deruxtecan (a new targeted drug) in people with prostate cancer that has spread beyond the prostate.  In the trial the researchers are comparing this new treatment with standard chemotherapy.  This is an international study, and they aim to recruit 1440 people in total.  More details of the trial can be found here.

We are not sure if any of the online community members are taking part in this trial.

If you did want to talk to someone who has already had treatment, as part of the study, it would be best to contact your research nurses at your local hospital as they may be able to make that connection for you.

If you want to talk through the principles of clinical trials or would like support with your decision making, you can also ring the specialist nurses on 0800 074 8383 (Monday to Friday 9am – 5pm).

With best wishes from,

The Moderating Team.

User
Posted 12 Nov 2026 at 11:56

Thank you very much for Your very professional answer. My husband is on the trial so I was just curios on how other People are responding 😊

 

br Susan 

 
Forum Jump  
©2026 Prostate Cancer UK